Induction of mitosis-mediated apoptosis by sodium arsenite in HeLa S3 cells

Biochemical Pharmacology

Volumn 60, Issue 6, 2000, Pages 771-780

  Huang, See Chang ^a   Huang, Chi Ying F ^b   Lee, Te Chang ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

2 aminopurine; Apoptosis; Arsenite; Caspase 3; Caspase 9; Cyclin B degradation; Mitotic arrest; Staurosporine

Indexed keywords

2 AMINOPURINE; ARSENITE SODIUM; CASPASE 3; CASPASE 9; CELL DNA; CYCLIN B; STAUROSPORINE;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL NUCLEUS MEMBRANE; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA DAMAGE; DRUG MECHANISM; ENZYME ACTIVATION; HELA CELL; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; MITOSIS; MITOSIS INDEX; PRIORITY JOURNAL; PROTEIN DEGRADATION;

APOPTOSIS; ARSENITES; CDC2 PROTEIN KINASE; CYCLIN B; DOWN-REGULATION; ENZYME INHIBITORS; HELA CELLS; HUMANS; MITOSIS; SODIUM COMPOUNDS;

EID: 0034666696     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00397-X     Document Type: Article

References (53)

1. Chen C.J., Chuang Y.C., Lin T.M., Wu H.Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan High-arsenic artesian well water and cancers . Cancer Res. 45:1985;5895-5899.
2. Wang Z., Rossman T.G. The carcinogenicity of arsenic. Chang L.W. Toxicology of Metals. 1996;221-229 CRC Press, New York.
3. 3) in the treatment of acute promyelocytic leukemia (APL) II. Clinical efficacy and pharmacokinetics in relapsed patients . Blood. 89:1997;3354-3360.
4. Kitamura K., Kiyoi H., Yoshida H., Tobita T., Takeshita A., Ohno R., Naoe T. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia Clinical and basic studies for the next generation . Cancer Chemother Pharmacol. 40:(Suppl):1997;S36-S41.
5. 3 exerts dose-dependent dual effects on APL cells . Blood. 89:1997;3345-3353.
6. Akao Y., Mizoguchi H., Kojima S., Naoe T., Ohishi N., Yagi K. Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro Activation of caspases and down-regulation of Bcl-2 protein . Br J Haematol. 102:1998;1055-1060.
7. Shao W., Fanelli M., Ferrara F.F., Riccioni R., Rosenauer A., Davison K., Lamph W.W., Waxman S., Pelicci P.G., Lo Coco F., Avvisati G., Testa U., Peschle C., Gambacorti-Passerini C., Nervi C., Miller W.H. Jr. Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells. J Natl Cancer Inst. 90:1998;124-133.
8. Wang Z.-G., Rivi R., Delva L., König A., Scheinberg D.A., Gambacorti-Passerini C., Gabrilove J.L., Warrell R.P. Jr, Pandolfi P.P. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARα independent manner. Blood. 92:1998;1497-1504.
9. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RARα/PML proteins . Blood. 88:1996;1052-1061.
10. Wang T.S., Kuo C.F., Jan K.Y., Huang H. Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J Cell Physiol. 169:1996;256-268.
11. Watson R.W., Redmond H.P., Wang J.H., Bouchier-Hayes D. Mechanisms involved in sodium arsenite-induced apoptosis of human neutrophils. J Leukoc Biol. 60:1996;625-632.
12. Zhu J., Koken M.H.M., Quignon F., Chelbi-Alix M.K., Degos L., Wang Z.Y., Chen Z., de Thé H. Arsenic-induced PML targeting onto nuclear bodies Implications for the treatment of acute promyelocytic leukemia . Proc Natl Acad Sci USA. 94:1997;3978-3983.
13. Huang S.C., Lee T.C. Arsenite inhibits mitotic division and perturbs spindle dynamics in HeLa S3 cells. Carcinogenesis. 19:1998;889-896.
14. Li W., Chou I.N. Effects of sodium arsenite on the cytoskeleton and cellular glutathione levels in cultured cells. Toxicol Appl Pharmacol. 114:1992;132-139.
15. Li Y.M., Broome J.D. Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells. Cancer Res. 59:1999;776-780.
16. Yih L.H., Ho I.C., Lee T.C. Sodium arsenite disturbs mitosis and induces chromosome loss in human fibroblasts. Cancer Res. 57:1997;5051-5059.
17. Sherwood S.W., Sheridan J.P., Schimke R.T. Induction of apoptosis by the anti-tubulin drug colcemid Relationship of mitotic checkpoint control to the induction of apoptosis in HeLa S3 cells . Exp Cell Res. 215:1994;373-379.
18. Jordan M.A., Wendell K., Gardiner S., Derry W.B., Copp H., Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56:1996;816-825.
19. Bhalla K., Ibrado A.M., Tourkina E., Tang C., Mahoney M.E., Huang Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia. 7:1993;563-568.
20. Murray A. Cell cycle checkpoints. Curr Opin Cell Biol. 6:1994;872-876.
21. Lee T.C., Wang-Wuu S., Huang R.Y., Lee K.C., Jan K.Y. Differential effects of pre- and posttreatment of sodium arsenite on the genotoxicity of methyl methanesulfonate in Chinese hamster ovary cells. Cancer Res. 46:1986;1854-1857.
22. Herrmann M., Lorenz H.M., Voll R., Grunke M., Woith W., Kalden J.R. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 22:1994;5506-5507.
23. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T.T., Yu V.L., Miller D.K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
24. Cohen G.M., Sun X.M., Snowden R.T., Ormerod M.G., Dinsdale D. Identification of a transitional preapoptotic population of thymocytes. J Immunol. 151:1993;566-574.
25. Wyllie A.H., Morris R.G. Hormone-induced cell death, Purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am J Pathol. 109:1982;78-87.
26. Lee T.C., Ko J.L., Jan K.Y. Differential cytotoxicity of sodium arsenite in human fibroblasts and Chinese hamster ovary cells. Toxicology. 56:1989;289-299.
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
28. cdc2 kinase and phosphatase. Biochem Biophys Res Commun. 190:1993;907-913.
29. Holloway S.L., Glotzer M., King R.W., Murray A.W. Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor. Cell. 73:1993;1393-1402.
30. Tam S.W., Schlegel R. Staurosporine overrides checkpoints for mitotic onset in BHK cells. Cell Growth Differ. 3:1992;811-817.
31. Andreassen P.R., Margolis R.L. 2-Aminopurine overrides multiple cell cycle checkpoints in BHK cells. Proc Natl Acad Sci USA. 89:1992;2272-2276.
32. King K.L., Cidlowski J.A. Cell cycle and apoptosis Common pathways to life and death . J Cell Biochem. 58:1995;175-180.
33. Milross C.G., Mason K.A., Hunter N.R., Chung W.K., Peters L.J., Milas L. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst. 88:1996;1308-1314.
34. King R.W., Jackson P.K., Kirschner M.W. Mitosis in transition. Cell. 79:1994;563-571.
35. Nurse P. Universal control mechanism regulating onset of M-phase. Nature. 344:1990;503-508.
36. cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ. 5:1994;1041-1050.
37. Gao C.Y., Zelenka P.S. Induction of cyclin B and H1 kinase activity in apoptotic PC12 cells. Exp Cell Res. 219:1995;612-618.
38. Shimizu T., O'Connor P.M., Kohn K.W., Pommier Y. Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res. 55:1995;228-231.
39. cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells. Cell Growth Differ. 9:1998;23-29.
40. Kung A.L., Zetterberg A., Sherwood S.W., Schimke R.T. Cytotoxic effects of cell cycle phase specific agents Result of cell cycle perturbation . Cancer Res. 50:1990;7307-7317.
41. Evan G.I., Brown L., Whyte M., Harrington E. Apoptosis and the cell cycle. Curr Opin Cell Biol. 7:1995;825-834.
42. King R.W., Glotzer M., Kirschner M.W. Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates. Mol Biol Cell. 7:1996;1343-1357.
43. Koepp D.M., Harper J.W., Elledge S.J. How the cyclin became a cyclin Regulated proteolysis in the cell cycle . Cell. 97:1999;431-434.
44. Stack J.H., Newport J.W. Developmentally regulated activation of apoptosis early in Xenopus gastrulation results in cyclin A degradation during interphase of the cell cycle. Development. 124:1997;3185-3195.
45. Klemperer N.S., Pickart C.M. Arsenite inhibits two steps in the ubiquitin-dependent proteolytic pathway. J Biol Chem. 264:1989;19245-19252.
46. Berleth E.S., Kasperek E.M., Grill S.P., Braunscheidel J.A., Graziani L.A., Pickart C.M. Inhibition of ubiquitin-protein ligase (E3) by mono- and bifunctional phenylarsenoxides. Evidence for essential vicinal thiols and a proximal nucleophile. J Biol Chem. 267:1992;16403-16411.
47. Huang R.N., Lee T.C. Arsenite efflux is inhibited by verapamil, cyclosporin A, and GSH-depleting agents in arsenite-resistant Chinese hamster ovary cells. Toxicol Appl Pharmacol. 141:1996;17-22.
48. Huang R.N., Lee T.C. Cellular uptake of trivalent arsenite and pentavalent arsenate in KB cells cultured in phosphate-free medium. Toxicol Appl Pharmacol. 136:1996;243-249.
49. Gjertsen B.T., Doskeland S.O. Protein phosphorylation in apoptosis. Biochim Biophys Acta. 1269:1995;187-199.
50. Ling Y.-H., Consoli U., Tornos C., Andreeff M., Perez-Soler R. Accumulation of cyclin B1, activation of cyclin B1-dependent kinase and induction of programmed cell death in human epidermoid carcinoma KB cells treated with taxol. Int J Cancer. 75:1998;925-932.
51. Zhu X.-H., Shen Y.-L., Jing Y.-K., Cai X., Jia P.-M., Huang Y., Tang W., Shi G.-Y., Sun Y.-P., Dai J., Wang Z.-Y., Chen S.-J., Zhang T.-D., Waxman S., Chen Z., Chen G.-Q. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst. 91:1999;772-778.
52. Yih L.H., Huang H.M., Jan K.Y., Lee T.C. Sodium arsenite induces ATP depletion and mitochondrial damage in HeLa cells. Cell Biol Int Rep. 15:1991;253-264.
53. Macho A., Decaudin D., Castedo M., Hirsch T., Susin S.A., Zamzami N., Kroemer G. Chloromethyl-X-Rosamine is an aldehyde-fixable potential-sensitive fluorochrome for the detection of early apoptosis. Cytometry. 25:1996;333-340.